Btcef TZ 250mg/31.25mg Injection
Marketer
Biotanic Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Btcef TZ 250mg/31.25mg Injection
Ceftazidime/Tazobactam 250mg/31.25mg Injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration should always be under a physician's direct supervision. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course of treatment is vital, even with symptom improvement. Premature cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects warrant immediate medical attention. Seek immediate medical help for any allergic reaction (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and ample hydration will facilitate recovery. Your doctor might order blood tests and other assessments to monitor the treatment's impact.
Uses of Btcef TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Btcef TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Btcef TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Btcef TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or their qualified staff; please do not attempt self-medication.
How Btcef TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactam (Btcef TZ 250mg/31.25mg Injection) work synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise inactivate Ceftriaxone, thus broadening its antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Btcef TZ 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Btcef TZ 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Btcef TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Btcef TZ 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Btcef TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Btcef TZ 250mg/31.25mg requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the dosage of Btcef TZ 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Btcef TZ 250mg/31.25mg Injection :
Omit a dose of Btcef TZ 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Btcef TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Agents against infection |
3,018 People bought this recently